ATE536181T1 - Metabolite von wortmannin-analogen und verwendungsverfahren dafür - Google Patents
Metabolite von wortmannin-analogen und verwendungsverfahren dafürInfo
- Publication number
- ATE536181T1 ATE536181T1 AT06851064T AT06851064T ATE536181T1 AT E536181 T1 ATE536181 T1 AT E536181T1 AT 06851064 T AT06851064 T AT 06851064T AT 06851064 T AT06851064 T AT 06851064T AT E536181 T1 ATE536181 T1 AT E536181T1
- Authority
- AT
- Austria
- Prior art keywords
- metabolites
- methods
- wortmannin
- analogues
- wortmannin analogues
- Prior art date
Links
- QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical class C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 title abstract 3
- 239000002207 metabolite Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 abstract 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000036952 cancer formation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000005740 tumor formation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75547705P | 2005-12-30 | 2005-12-30 | |
| PCT/US2006/062716 WO2007120364A2 (en) | 2005-12-30 | 2006-12-29 | Metabolites of wortmannin analogs and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE536181T1 true ATE536181T1 (de) | 2011-12-15 |
Family
ID=38610016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06851064T ATE536181T1 (de) | 2005-12-30 | 2006-12-29 | Metabolite von wortmannin-analogen und verwendungsverfahren dafür |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7723375B2 (de) |
| EP (1) | EP1965790B1 (de) |
| AT (1) | ATE536181T1 (de) |
| AU (1) | AU2006342055B2 (de) |
| CA (1) | CA2636040C (de) |
| ES (1) | ES2378780T3 (de) |
| PL (1) | PL1965790T3 (de) |
| WO (1) | WO2007120364A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2416771A4 (de) * | 2009-04-09 | 2012-10-31 | Oncothyreon Inc | Verfahren und zusammensetzungen aus pi-3-kinasehemmern zur fibrosebehandlung |
| WO2012118978A1 (en) * | 2011-03-03 | 2012-09-07 | The Regents Of The University Of Colorado, A Body Corporate | Methods for treating oncovirus positive cancers |
| US11197854B1 (en) | 2018-11-14 | 2021-12-14 | National Technology & Engineering Solutions Of Sandia, Llc | Inhibitors for targeting flaviviruses |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001064A (en) | 1988-06-20 | 1991-03-19 | Washington University | Phosphatidylinositol 4-kinase |
| DE68922497T2 (de) | 1988-08-24 | 1995-09-14 | Marvin J Slepian | Endoluminale dichtung mit bisdegradierbaren polymeren. |
| US5504103A (en) | 1993-08-25 | 1996-04-02 | Eli Lilly And Company | Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof |
| US5480906A (en) | 1994-07-01 | 1996-01-02 | Eli Lilly And Company | Stereochemical Wortmannin derivatives |
| CA2193234A1 (en) * | 1994-07-01 | 1996-01-18 | Brian Kai-Ming Cheng | Process for preparing n-phosphonomethylamino carboxylic acids |
| US5602278A (en) | 1994-10-20 | 1997-02-11 | Kirkpatrick; Lynn | N-oxides and derivatives of chlorambucil for treating hypoxic tumor cells |
| GB2302021A (en) | 1996-10-16 | 1997-01-08 | Lilly Co Eli | Inhibiting bone loss or resorption |
| ATE334671T1 (de) * | 2001-09-14 | 2006-08-15 | Univ Arizona | Wortmanninanaloge und verfahren zu deren verwendung |
| US7081475B2 (en) | 2001-09-14 | 2006-07-25 | Prolx Pharmaceuticals Corp. | Wortmannin analogs and methods of using same |
| US6703414B2 (en) | 2001-09-14 | 2004-03-09 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Device and method for treating restenosis |
| CA2578336C (en) | 2004-07-09 | 2013-09-24 | Prolx Pharmaceuticals Corp. | Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| JP2008515984A (ja) | 2004-10-13 | 2008-05-15 | ワイス | Ｐｉ３ｋ阻害剤としての１７−ヒドロキシワートマニンの類似体 |
-
2006
- 2006-12-29 EP EP06851064A patent/EP1965790B1/de active Active
- 2006-12-29 CA CA2636040A patent/CA2636040C/en not_active Expired - Fee Related
- 2006-12-29 WO PCT/US2006/062716 patent/WO2007120364A2/en active Application Filing
- 2006-12-29 ES ES06851064T patent/ES2378780T3/es active Active
- 2006-12-29 AT AT06851064T patent/ATE536181T1/de active
- 2006-12-29 AU AU2006342055A patent/AU2006342055B2/en not_active Ceased
- 2006-12-29 US US11/618,036 patent/US7723375B2/en not_active Expired - Fee Related
- 2006-12-29 PL PL06851064T patent/PL1965790T3/pl unknown
-
2010
- 2010-04-01 US US12/752,935 patent/US20100249205A1/en not_active Abandoned
-
2011
- 2011-06-10 US US13/158,260 patent/US8586626B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2378780T3 (es) | 2012-04-17 |
| EP1965790A2 (de) | 2008-09-10 |
| WO2007120364A2 (en) | 2007-10-25 |
| CA2636040C (en) | 2013-12-17 |
| EP1965790B1 (de) | 2011-12-07 |
| US20070191466A1 (en) | 2007-08-16 |
| US20100063129A9 (en) | 2010-03-11 |
| AU2006342055B2 (en) | 2012-05-24 |
| EP1965790A4 (de) | 2009-06-24 |
| PL1965790T3 (pl) | 2012-05-31 |
| US20100249205A1 (en) | 2010-09-30 |
| US8586626B2 (en) | 2013-11-19 |
| US7723375B2 (en) | 2010-05-25 |
| AU2006342055A1 (en) | 2007-10-25 |
| CA2636040A1 (en) | 2007-10-25 |
| WO2007120364A3 (en) | 2008-07-24 |
| US20110263672A1 (en) | 2011-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301145I2 (nl) | Tirbanibulin | |
| ATE517896T1 (de) | P38-kinase-inhibitoren | |
| EP3677584A4 (de) | Verbindung mit bruton-tyrosinkinase (btk)-hemmung und abbau | |
| BRPI0412918A (pt) | inibidores de quinases p38 | |
| ATE408412T1 (de) | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration | |
| MA33974B1 (fr) | Combinaisons d'un inhibiteur de pi3k et d'un inhibiteur de mek | |
| EA200501563A1 (ru) | Пролекарства ингибиторов киназы pi-3 | |
| ECSP088440A (es) | Imidazopirazinas como inhibidores de proteinquinasa | |
| MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
| BRPI0515518A (pt) | análogos de loxapina e métodos de usos dos mesmos | |
| ATE400319T1 (de) | Tetrahydropyridothiophene | |
| NO20072179L (no) | Kombinasjon av en SRC kinase inhibitor og en. BCR-ABL inhibitor for behandling av proleferative sykdommer | |
| CL2007002382A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel. | |
| ATE435858T1 (de) | Prodrugs von als erk-proteinkinase-inhibitoren wirkenden pyrrolylpyrimidinen | |
| ATE542796T1 (de) | N-sulfonylcarboximidamidverbindungen als apoptosepromotoren | |
| NO20081292L (no) | Pentasykliske kinaseinhibitorer | |
| BRPI0507859A (pt) | uso dos inibidores da colinesterase | |
| GB0402138D0 (en) | Novel compounds | |
| ATE536181T1 (de) | Metabolite von wortmannin-analogen und verwendungsverfahren dafür | |
| RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS | |
| ATE508750T1 (de) | Derivate von vitamin d und ihre verwendung in der therapie | |
| MX2007004040A (es) | Uso para alfa-simpatomimeticos con estructura de 2-imidazolina. | |
| ES1058914Y (es) | Delimitador portatil del terreno de juego | |
| NO20071942L (no) | Quinolone analoger. | |
| GT200600016A (es) | Compuestos farmaceuticos |